Impact of mutant STK11, KEAP1, and KRAS on firstline chemoimmunotherapy survival outcomes in metastatic non-small cell lung cancer (NSCLC): A meta-analysis of randomized and comparative studies.
Authors: Suvarna Guvvala, Ankita Gupta, Sireesha Vutukuri, Philip A. Haddad
Published: 2025-05-28
DOI:
10.1200/jco.2025.43.16_suppl.e20504
Source:
Full article
Abstract
e20504